"Based on currently available information (primarily from clinical trials), the types of side effects associated with ecnoglutide are expected to be similar to those of existing GLP-1 receptor agonists (such as semaglutide or dulaglutide), primarily including gastrointestinal disorders (diarrhea, nausea, vomiting) and decreased appetite
These mitochondrial morphological changes may be related to high gene expression and the ability to stimulate the activity of the P53 tumor suppressor protein (Teulings et al., 2013) and SOD enzymes (Laddha et al., 2013)
in such cases, direct treatment of the tumor or use of different therapy is needed instead
These include reduced risks of heart attack, stroke, and cardiovascular death in patients with type 2 diabetes or obesity and established heart disease
discuss with your prescriber
This is because shots enable the body to absorb vitamin B12 without going through the digestive system